Research to Treat Neurodegenerative Diseases Advances: URMC Start-up Acquired
Oscine Therapeutics – a biotechnology company that is developing cell-based therapies for neurological disorders based on discoveries made at the University of Rochester Medical Center (URMC) – has been acquired by Sana Biotechnology for undisclosed terms. The research behind Oscine is based on decades of work in the lab of Steve Goldman,